ELPA Stakeholders’ Meeting is held annually and is created to serve as a means of exchanging ideas and proposals, as well as to help sinchronise policy activities of relevant liver disease stakeholders.

This year's Stakeholders' meeting was held on 26 November back to back to our EGM and Advisory Board meetings in Ljubljana. Attended by ELPA members and our partners in the field, we have used the opportunity to present our highlights in 2018, as well as the plans for 2019. Traditionally, ELPA has always included its most important stakeholders in the discussion in order to align on activities where possible and detect the possibilities for new collaborations. 

This year our agenda included: Prof. dr. Mojca Matičič, MD, Head of the Viral Hepatitis Unit at the Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, and Head of the Outpatient STI Service at the same University Medical Centre, who gave the presentation of Slovenian model for hepatitis C elimination; Ddr. Klemen Jaklič, Judge at the Slovenian Constitutional Court, professor of law at Harvard University, who spoke about the Health as a Fundamental Human Right; Prof. dr. Rui Tato Marinho, International Symposium on Hepatitis Care in Substance Users (INHSU); Luis Mendao, European AIDS Treatment Group (EATG); Antons Mozalevskis, WHO Europe; Greet Hendrix, Viral Hepatitis Prevention Board (VHPB); Neil Causey, ACHIEVE Coalition and Ekaterina Gorbunova, Global Parliamentarians Network to End HIV/AIDS, Viral hepatitis and